Regulatory documentation and scientific communications are far too important to be left to chance. No programme is too small for well-written protocols, study reports or submission dossiers. The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and reviewer-friendliness of the documentation.
At Trilogy, medical writing is our passion. As specialists in regulatory documentation, we provide a service that is more than just writing. We work as an outsourcing partner for our clients, and our writers are integral parts of our clients’ teams: proactively planning, coordinating and writing their regulatory documentation to meet timelines, with a readability that reduces the time for review and approval.
We have been helping pharmaceutical companies and clinical research organisations (CROs) of all sizes, worldwide, to streamline their documentation processes for 20 years. If you are looking for ways to save time and money in your pre- and post-marketing programmes, Trilogy can help. We will be happy to talk to you about how to increase the speed and effectiveness of your documentation. Please take a look around our website and contact us for more information.
Dr. Julia Forjanic Klapproth, Senior Partner
“We truly understand our clients’ data and work with them to make a meaningful document.”
“For submission experience you need to use Trilogy. Period.”
“Becoming a leader in our field. Our Way”
Trilogy Writing & Consulting, a company specialised in regulatory writing, announced that one of its Senior Partners, Julia Forjanic Klapproth, was honored with the Harold Swanberg Distinguished Service Award during the AMWA conference that took place in Denver, CO, in the beginning of November 2022.
This award is a recognition of Julia’s “almost obsessive passion for medical writing and its importance to the pharmaceutical industry and the world.”